Eculizumab for the treatment of atypical hemolytic uremic syndrome - Case report and revision of the literature von Vaisbich, Maria Helena, Henriques, Luciana dos Santos, Watanabe, Andréia, Pereira, Lilian Monteiro, Metran, Camila Cardoso, Malheiros, Denise Avancini, Modanez, Flávia, Silva, João Domingos Montoni da, Vieira, Simone, Macedo, Ana Catarina Lunz, Massarope, Bianca, Furusawa, Érika Arai, Schvartsman, Benita Galassi Soares

Volltext

Mycoplasma arthritidis superantigen (MAM)-induced macrophage nitric oxide release is MHC class ii restricted, interferonγ dependent, and toll-like receptor 4 independent von Ribeiro-Dias, Fátima, Shio, Marina Tiemi, Timenetsky, Jorge, Oliane, Ana Paula Camilo, Metran, Camila Cardoso, Pessoa, Fábio Borges, Jancar, Sonia

Volltext

Mycoplasma arthritidis superantigen (MAM)-induced macrophage nitric oxide release is MHC class II restricted, interferongamma dependent, and toll-like receptor 4 independent von Ribeiro-Dias, Fátima, Shio, Marina Tiemi, Timenetsky, Jorge, Oliane, Ana Paula Camilo, Metran, Camila Cardoso, Pessoa, Fábio Borges, Jancar, Sonia

Volltext